Concepedia
Statistics
Publications
8
Citations
206
H-Index
Active since
2017
Affiliations
Michigan State University(Current)
Dartmouth College
Northeastern University
Dartmouth Psychiatric Research Center
Sarah Carapellucci is an author at Michigan State University specializing in oncology, pharmacology, and medicine.
Publications per year
2017–2022
A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient mice
Di Zhang, Paige Baldwin, Ana S. Leal et al. · Theranostics · 2019 · 66 citations · Full text
Pharmacy, Oncology, Pharmacology +17
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models
Ana S. Leal, Kayla Zydeck, Sarah Carapellucci et al. · npj Breast Cancer · 2019 · 33 citations · Full text
Medicine, Immunology, Oncology +15
Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
Di Zhang, Ana S. Leal, Sarah Carapellucci et al. · Cancer Prevention Research · 2017 · 27 citations · Full text
Medicine, Oncology, Pharmacology +14
Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention
Di Zhang, Ana S. Leal, Sarah Carapellucci et al. · Cancer Prevention Research · 2019 · 19 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +10
The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer
Jessica A. Moerland, Di Zhang, Lyndsey A. Reich et al. · Scientific Reports · 2020 · 17 citations · Full text
1–5 of 8